Study on clinical efficacy of Qidong Huoxue Yin in the treatment of acute lung injury
- Conditions
- acute lung injury
- Registration Number
- ITMCTR2100005190
- Lead Sponsor
- The Second Affiliated Hospital of Zhengjiang University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
1. According to the diagnostic criteria of ALI;
2. Patients admitted to our hospital for treatment and mechanical ventilation;
3. Age between 18-85 years old;
4. Without tumor or autoimmune disease;
5. Did not participate in the clinical study of other drugs within one month;
6. Volunteer to participate in this research, and sign the informed consent.
1. Pulmonary edema due to hypoproteinemia due to cardiogenic pulmonary edema, acute pulmonary embolism, liver and kidney disease, or malnutrition, atelectasis due to atelectasis, pulmonary edema due to tumor compression or pulmonary fibrosis, pulmonary edema due to upper airway obstruction, and any medical history that, according to the investigator's judgment, could interfere with the test results or increase the patient's risk of treatment;
2. With drug allergy or intolerance on this test;
3. Pregnant or lactating women;
4. Psychiatric patients;
5. Patients who are participating in clinical trials of other drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic evaluation standard of ALI;Chinese Rating Scale;
- Secondary Outcome Measures
Name Time Method ALI Murray score;APACHE II score;